A. J. Plummer

1.4k total citations
51 papers, 1.1k citations indexed

About

A. J. Plummer is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, A. J. Plummer has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Biochemistry and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in A. J. Plummer's work include Eicosanoids and Hypertension Pharmacology (12 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Receptor Mechanisms and Signaling (6 papers). A. J. Plummer is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (12 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Receptor Mechanisms and Signaling (6 papers). A. J. Plummer collaborates with scholars based in United States and Norway. A. J. Plummer's co-authors include R.A. Maxwell, Jürg Schneider, J. H. Trapold, Falk Schneider, Robert Mull, Herbert Sheppard, Lloyd B. Witkin, E. O’Keefe, Thomas F. Mowles and Robert A. Maxwell and has published in prestigious journals such as Nature, Circulation Research and Annals of the New York Academy of Sciences.

In The Last Decade

A. J. Plummer

51 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. J. Plummer United States 17 258 193 158 157 136 51 1.1k
H. J. Bein Switzerland 12 154 0.6× 168 0.9× 127 0.8× 81 0.5× 133 1.0× 30 762
Anton H. M. Jageneau Belgium 16 245 0.9× 197 1.0× 112 0.7× 138 0.9× 93 0.7× 39 1.0k
L Szporny Hungary 16 239 0.9× 250 1.3× 88 0.6× 108 0.7× 151 1.1× 89 829
Sidney M. Hess United States 20 519 2.0× 401 2.1× 117 0.7× 204 1.3× 122 0.9× 34 1.2k
Curt C. Porter United States 18 512 2.0× 371 1.9× 100 0.6× 291 1.9× 149 1.1× 38 2.0k
G. Kroneberg Germany 15 304 1.2× 206 1.1× 68 0.4× 153 1.0× 85 0.6× 67 790
F.E. Shideman United States 19 447 1.7× 305 1.6× 52 0.3× 145 0.9× 106 0.8× 74 1.2k
Irwin H. Slater United States 12 229 0.9× 197 1.0× 52 0.3× 92 0.6× 92 0.7× 23 654
L. R. Gjessing Norway 21 240 0.9× 139 0.7× 91 0.6× 191 1.2× 147 1.1× 76 1.3k
R T Brittain United Kingdom 20 474 1.8× 333 1.7× 68 0.4× 412 2.6× 170 1.3× 46 1.4k

Countries citing papers authored by A. J. Plummer

Since Specialization
Citations

This map shows the geographic impact of A. J. Plummer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Plummer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Plummer more than expected).

Fields of papers citing papers by A. J. Plummer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Plummer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Plummer. The network helps show where A. J. Plummer may publish in the future.

Co-authorship network of co-authors of A. J. Plummer

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Plummer. A scholar is included among the top collaborators of A. J. Plummer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Plummer. A. J. Plummer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochoa, Enrique L. M., et al.. (1990). Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.. Molecular Pharmacology. 38(6). 863–871. 8 indexed citations
2.
Plummer, A. J., et al.. (1966). AGE, CONFINEMENT AND AGGREGATION AS FACTORS IN AMPHETAMINE GROUP TOXICITY IN MICE. Journal of Pharmacology and Experimental Therapeutics. 154(2). 346–349. 6 indexed citations
3.
Plummer, A. J., et al.. (1962). A PHARMACOLOGICAL INVESTIGATION OF AN ETHER OF METHYL EPIRESERPATE. Journal of Pharmacology and Experimental Therapeutics. 138(1). 78–81. 3 indexed citations
4.
Huebner, Charles F., et al.. (1961). A pharmacologic investigation of dimethpyrindene maleate (forhistal®). Toxicology and Applied Pharmacology. 3(5). 534–544. 11 indexed citations
5.
Sheppard, Herbert, Thomas F. Mowles, & A. J. Plummer. (1960). Determination of Hydrochlorothiazide in Urine**Received October 12, 1959, from the Research Department, Ciba Pharmaceutical Products Inc., Summit N. J.. Journal of the American Pharmaceutical Association (Scientific ed ). 49(11). 722–723. 25 indexed citations
6.
Maxwell, R.A., et al.. (1960). PHARMACOLOGY OF [2-(OCTAHYDRO-1-AZOCINVL)-ETHYL-GUANIDINE SULFATE (SU-5864). Journal of Pharmacology and Experimental Therapeutics. 128(1). 22–29. 25 indexed citations
7.
Maxwell, R.A., et al.. (1960). CONCERNING A POSSIBLE ACTION OF GUANETHIDINE (SU-5864) IN SMOOTH MUSCLE. Journal of Pharmacology and Experimental Therapeutics. 129(1). 24–30. 42 indexed citations
8.
Maxwell, R.A., et al.. (1960). DIFFERENTIAL POTENTIATION OF NOREPINEPHRINE AND EPINEPHRINE BY CARDIOVASCULAR AND CNS-ACTIVE AGENTS. Journal of Pharmacology and Experimental Therapeutics. 128(2). 140–144. 7 indexed citations
9.
Maxwell, R.A., et al.. (1960). Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).. PubMed. 128. 22–9. 129 indexed citations
10.
Maxwell, R.A., et al.. (1958). CONCERNING THE MECHANISMS OF THE CARDIOVASCULAR ACTIONS OF HEXAHYDRO-1-AZEPINEPROPIONAMIDOXIME (SU-4029). Journal of Pharmacology and Experimental Therapeutics. 124(2). 127–134. 9 indexed citations
11.
Maxwell, Robert A., et al.. (1957). Cardiovascular Response of the Anesthetized Hamster to Reserpine and Ganglionic Blockade. Circulation Research. 5(4). 414–418. 2 indexed citations
12.
Maxwell, R.A., et al.. (1956). Effects of Reserpine on Urinary Bladder Tension. Experimental Biology and Medicine. 92(1). 227–230. 4 indexed citations
13.
Sheppard, Herbert, et al.. (1956). The Detection of Glutethimide (Doriden®) and a Metabolite in Dog Urine*. Journal of the American Pharmaceutical Association (Scientific ed ). 45(10). 681–684. 23 indexed citations
14.
Schneider, Jürg, et al.. (1955). NEUROPHARMACOLOGICAL ASPECTS OF RESERPINE. Annals of the New York Academy of Sciences. 61(1). 17–26. 41 indexed citations
15.
Plummer, A. J., et al.. (1955). GANGLIONIC BLOCKADE BY A NEW BISQUATERNARY SERIES, INCLUDING CHLORISONDAMINE DIMETHOCHLORIDE. Journal of Pharmacology and Experimental Therapeutics. 115(2). 172–184. 42 indexed citations
16.
Schlittler, E., Jürg Schneider, & A. J. Plummer. (1954). Über Rauwolfia‐Alkaloide. Angewandte Chemie. 66(13-14). 386–390. 6 indexed citations
17.
Trapold, J. H., et al.. (1954). CARDIOVASCULAR AND RESPIRATORY EFFECTS OF SERPASIL, A NEW CRYSTALLINE ALKALOID FROM RAUWOLFIA SERPENTINA BENTH, IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 110(2). 205–214. 27 indexed citations
18.
19.
Plummer, A. J., et al.. (1953). Inhibition of ulcer formation in the Shay rat and reduction of gastric acidity in dogs by antrenyl (oxyphenonium) (BA5473) diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenyl-cyclohexaneglycolate, an anticholinergic agent.. PubMed. 108(3). 305–16. 11 indexed citations
20.
Plummer, A. J., et al.. (1953). PHARMACOLOGIC PROPERTIES OF ANTRENYL (OXYPHENONIUM) (BA-5473) DIETHYL(2-HYDROXYETHYL)METHYLAMMONIUM BROMIDE α-PHENYL-CYCLOHEXANEGLYCOLATE, AN ANTICHOLINERGIC AGENT. Journal of Pharmacology and Experimental Therapeutics. 108(3). 292–304. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. J. Bein Breakdown of academic impact, for papers by Anton H. M. Jageneau Breakdown of academic impact, for papers by L Szporny Breakdown of academic impact, for papers by Sidney M. Hess Breakdown of academic impact, for papers by Curt C. Porter Breakdown of academic impact, for papers by G. Kroneberg Breakdown of academic impact, for papers by F.E. Shideman Breakdown of academic impact, for papers by Irwin H. Slater Breakdown of academic impact, for papers by L. R. Gjessing Breakdown of academic impact, for papers by R T Brittain
Rankless by CCL
2026